Sign In
Buy INSM
$106.92
-0.490 (-0.456%)
At Close: Jul 24, 2026
Is Sally Beauty Holdings, Inc. (SBH) Going to Burn These Hedge Funds?
09:18pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Are Crazy About Insmed Incorporated (INSM)
07:33pm, Tuesday, 07'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Insmed Incorporated (NASDAQ:INSM) Shares Sold by AQR Capital Management LLC
09:46am, Monday, 06'th Apr 2020
AQR Capital Management LLC cut its stake in Insmed Incorporated (NASDAQ:INSM) by 13.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12:00pm, Friday, 03'rd Apr 2020
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Insmed (NASDAQ:INSM) Lowered to Strong Sell at BidaskClub
07:24am, Friday, 03'rd Apr 2020
Insmed (NASDAQ:INSM) was downgraded by equities research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday, BidAskClub reports. Seve
BRIEF-Insmed Appoints Carol A. Schafer To Its Board Of Directors
12:04pm, Thursday, 02'nd Apr 2020
Insmed Inc:
Insmed Appoints Carol A. Schafer to its Board of Directors
12:00pm, Thursday, 02'nd Apr 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of Carol A. Schafe
Insmed Incorporated (NASDAQ:INSM) Receives Consensus Recommendation of "Buy" from Analysts
05:58am, Thursday, 02'nd Apr 2020
Shares of Insmed Incorporated (NASDAQ:INSM) have been assigned an average recommendation of “Buy” from the eleven research firms that are currently covering the firm, MarketBeat reports. One resea
Great West Life Assurance Co. Can Invests $133,000 in Insmed Incorporated (NASDAQ:INSM)
11:13am, Sunday, 29'th Mar 2020
Great West Life Assurance Co. Can bought a new stake in shares of Insmed Incorporated (NASDAQ:INSM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commissi
Amalgamated Bank Grows Stake in Insmed Incorporated (NASDAQ:INSM)
08:30am, Sunday, 29'th Mar 2020
Amalgamated Bank boosted its position in shares of Insmed Incorporated (NASDAQ:INSM) by 18.1% during the 4th quarter, HoldingsChannel reports. The firm owned 16,245 shares of the biopharmaceutical com
Dynamic Technology Lab Private Ltd Makes New $258,000 Investment in Insmed Incorporated (NASDAQ:INSM)
12:08pm, Thursday, 26'th Mar 2020
Dynamic Technology Lab Private Ltd purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM) during the fourth quarter, according to the company in its most recent Form 13F filing with t
Insmed (NASDAQ:INSM) Stock Rating Lowered by ValuEngine
06:54am, Tuesday, 24'th Mar 2020
Insmed (NASDAQ:INSM) was downgraded by research analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued on Tuesday, ValuEngine reports. Other equities res
Insmed (INSM) Gets a Buy Rating from H.C. Wainwright
09:27am, Sunday, 22'nd Mar 2020
In a report issued on March 17, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Insmed (INSM –
Zacks: Brokerages Anticipate Insmed Incorporated (NASDAQ:INSM) to Post -$0.63 Earnings Per Share
09:04am, Sunday, 22'nd Mar 2020
Wall Street brokerages expect Insmed Incorporated (NASDAQ:INSM) to announce earnings of ($0.63) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates
Insmed Incorporated (NASDAQ:INSM) Shares Sold by Alyeska Investment Group L.P.
08:40am, Friday, 20'th Mar 2020
Alyeska Investment Group L.P. lessened its stake in shares of Insmed Incorporated (NASDAQ:INSM) by 46.4% during the fourth quarter, according to the company in its most recent disclosure with the Secu
